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Prostaglandins Fail to Elevate Cyclic AMP Levels in Mouse Epidermis 
In Vivo and In Vitro 
SEYMOUR J. GARTE, PH .D. AND SID NEY BELMAN, PH.D. 
Institute of Environmental Medicine, New Yorh University Medical Center, New Yorh, New Yorh, U.S.A. 
Prostaglandin E t had no effect on mouse epidermal 
cyclic AMP levels either when applied percutaneously 
to shaven skin or when incubated in vitro with epider-
mal homogenates. Neither prostaglandin E 1 nor E 2 had 
any effect on cyclic AMP levels in a line of cultured 
mouse epidermal cells at doses from 0.1-10 J.LM. 
Prostaglandins have been shown to elevate cyclic AMP in a 
large number of tissues and cells [1]. E levated prostaglandin 
and cAMP levels are well correlated in human breast t umors 
[2]. In rat macrophages the ionophore A23187 raises cAMP 
levels by first stimulating prostaglandin E formation, which in 
turn mediates the rise in cAMP [3]. 
The potent mouse skin tumor promoter, phorbol myristate 
acetate (PMA), has been shown to stimulate prostaglandin 
formation in mouse skin in vivo [4] and in vitro [5,6] as well 
as in other cell types [7,8]. Since PMA does not elevate cAMP 
levels in mouse skin [9,10], it seemed possible t hat P MA might 
be uncoupling the adenyl cyclase response to prostaglandin , as 
has been shown for the {J-adrenergic response [11]. An alter-
native explanation is that, unlike most tissues including pig, 
guinea pig, and human skin [12,13], mouse skin does not 
normally respond to prostaglandin with an increase in cAMP 
accumulation. Prostaglandin E2 has been shown to enhance the 
normal ischemia-induced ris.e in cAMP in mouse epidermis 
[14], but no data were given on PGE~ effects on basal levels. 
On the other hand, Marks et a! [15], found no increase in 
mouse epidermal cAMP after topical administration of pros-
taglandin E~ . We now confirm and extend these findings to 
show t hat prostaglandin E 1 does not stimulate cAMP accumu-
lation in mouse skin in vivo or in epidermal homogenates in 
vitro, and that PGE1 and PGE2 do not affect cAMP levels in 
cul tured mouse epidermal cells. 
MATERIALS AND METHODS 
Female 8-week-old Ha/ICR mice were shaved, treated percuta-
neously on the dorsal skin with 25 1-'g PGE 1 (Sigma, St. Louis, Missouri) 
in 0.2 ml acetone, or 0.2 ml acetone alone. Groups of 5 mice each were 
sacrificed at various t imes afte r treatment . Immediate ly afte r sacrifice 
by cervical dislocation, t he a nimals were plunged into liquid nitrogen 
for 35 s and the epidermis was scraped off t he frozen skin with a 
scalpel, homogenized in trich loroacetic ac id (TCA), and extracted with 
ether as previously described [10]. Cyclic AMP was determined by 
radioimmunoassay [10] with reagents purchased from Collaborative 
Research (Waltham, Massachusetts) and DNA was determined by a 
lluorometric procedure [1 6]. 
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In Vitro Experiments 
Sk ins from 12 mice were excised immediately after sacrifice and 
froze n in liquid nitrogen. Epidermis was removed by scraping and 
homogenized in 3 ml 0.1 M phosphate-buffered saline (PBS) , pH 7.2 
per epidermis with 15 strokes in a loose Dounce homoge nizer. Epider-
mal homogenate was incubated with 300 !lM GTP and 10 1-<M PGE 1 in 
a total of 3 ml at 37"C wit h shaki ng for various times. Prostagla ndin 
E 1 was originally dissolved in ethanol. At the end of the incubation 
period, 0.2 ml 100% TCA was added and t he mixture was rapidly cooled 
and homogenized. Cyclic AMP and DNA were determined as above. 
Cell Culture 
Establishment of a cell line from neonatal C57BL mouse epidermis 
using procedures adapted from Yuspa and Harris [1 7] has been de-
scribed [18]. The cells were grown in modified Eagle's medium (Gibco) 
supplemented with 10% feta l bovine serum (Reheis) in 60-mm plastic 
dishes until confluent. Medium was replaced with PBS containing 
va rious concentrations of prostaglandins made from a stock solut ion. 
F ina l concentration of ethanol in dishes was 0.1 %. After 10-min incu-
bation, prostaglandin solution was removed, and cells were scraped off 
t he dishes in cold 6% TCA. Extraction and a nalys is of cyclic AMP and 
DNA were performed as described previously [10,16]. 
RESULTS AND DISCUSSION 
As shown in Table I, PGE 1 had no statistica lly significant 
effect on cAMP levels of mouse epidermis in vivo or in vitro. 
Using the same in vitro epidermal homogenate system, we were 
able to previously demonstrate a 7- to 10-fold stimulation of 
cAMP accumulation after incubation with isoproterenol (11] . 
Dose-response studies of both prostaglandin E 1 and E~ showed 
no effect by either agent on cyclic nucleotide levels in cul tured 
mouse epidermal cells (Table II). It should be noted that this 
cell line is as responsive to isoproterenol stimulation of cyclic 
AMP as mouse epiderm is in vivo [18]. 
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Topical t reatment of labile prostaglandins may be ineffective 
in elevating ep idermal cyclic AMP due to insufficient dose to 
the target cells. On the other hand, topical application of 
prostaglandins to mouse skin has been shown to produce other 
biologic effects [19,20]. Our results with dose response of both 
PGEs in cu ltured mouse epidermal cells, when taken with the 
in vivo and in vitro treatment data on mouse epidermal t issue 
presented here and the results of Marks et al [15], indicate t hat 
TABLE I. Effect of prostaglandin. E 1 on cA MP levels in mouse 
epidermis in vivo and in epidermal homogenates in _vitro 
Treatment t ime" cA MP leve l• (pmol/11g DNA) 
(min) 
Control 
2.5 
5.0 
10.0 
15.0 
30.0 
60.0 
.224 ± .053 
NO' 
.179 ± .014 
.220 ± .038 
.189 ± .051 
.181 ± .026 
.131 ± .008 
ln vitro 
.450 ± .048 
.403 ± .026 
.457 ± .010 
.633 ± .063 
NO 
NO 
NO 
"Time between treatment and sacrifice for in vivo studies, a nd 
incubation period for in vit ro studies. 
b Mean ± SEM of 5 replicate determination in each group. No 
statistical significance at p .;; 0.10 by Student's t-test found for any 
t reatment group compared to cont rol. 
' NO = not determined. 
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TABLE II. Dose response of prostaglandin effect on cA MP levels in. 
cultured mouse epidermal celL5 
Dose" 
(pM) 
0 
0.1 
0.3 
1.0 
3.0 
10.0 
cA MP (pmole/pg DNA) 
PGE 1 PGE 2 
1.05 ± 0.07 
1.34±0.17 
0.86 ± 0.05 
1.09 ± 0.05 
1.08 ± 0.18 
1.18 ± 0.21 
1.18 ± 0.12 
NDb 
0.983 ± O.D78 
0.959 ± 0.102 
0.899 ± 0.066 
0.992 ± 0.057 
"PGE 1 or PGE 2 was incubated with cells for 10 min. 
b ND = not determ ined. 
mouse epidermis is unusual in its respons~ to prostaglandin. 
This is an important finding with respect to mechanisms of 
skin tumor promotion with PMA, which occurs only in mouse 
skin. The pharmacology of prostaglandin action in mouse skin 
needs to be further investigated since prostaglandin, but not 
cAMP, is elevated by PMA treatment. 
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